Evidence for autoimmunity in amyotrophic lateral sclerosis

Area of Science:

• Neuroimmunology
• Neurodegenerative Diseases

Background:

• The exact causes of Amyotrophic Lateral Sclerosis (ALS) remain unknown.
• Growing evidence suggests autoimmune processes may play a role in motoneuron degeneration in ALS.

Purpose of the Study:

• To investigate the potential role of autoimmune mechanisms in ALS pathogenesis.
• To explore the effects of immunoglobulin G (IgG) from ALS patients on neuromuscular function.

Main Methods:

• Induction of an experimental autoimmune gray matter disease in an animal model.
• Analysis of spinal cord inflammation, IgG deposition, and motoneuron integrity.
• Passive transfer of ALS patient IgG to mice to assess neuromuscular junction (NMJ) physiology.
• Investigation of ALS IgG interaction with calcium channels.

Main Results:

• The animal model exhibited weakness, motoneuron loss, and inflammation, mimicking aspects of human ALS.
• IgG was found at the NMJ and within upper and lower motoneurons (UMN/LMN) in both the animal model and human ALS.
• ALS IgG passively transferred NMJ physiological changes to mice, enhancing acetylcholine release.
• ALS IgG selectively interacted with and altered calcium channel function.

Conclusions:

• Autoimmune mechanisms are implicated in the destruction and loss of motoneurons in ALS.
• ALS patient IgG can directly impact neuromuscular function, suggesting a pathogenic role.
• Targeting autoimmune pathways may offer therapeutic strategies for ALS.